CNTXContext Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Context Therapeutics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNTXEsta | $34M#8 | — | 0.9x#6 | — | — | -35.2%#9 | — | -94.6%#7 | — | — | -54.4%#4 | — |
| SCYX | $41M#1 | 14.8x#4 | 0.6x#4 | 2.0x#5 | 449.9%#1 | 59.6%#2 | -78.0%#3 | -12.9%#2 | — | 7#1 | -52.1%#3 | — |
| ATNM | $40M#2 | 3.6x#3 | 1.3x#8 | 443.7x#11 | — | 11.4%#5 | -40274.4%#11 | -111.8%#8 | — | — | -22.8%#1 | — |
| VERU | $40M#3 | — | 1.4x#9 | 2.4x#6 | 3.6%#3 | 39.9%#3 | -146.6%#5 | -80.1%#6 | -399.3%#4 | — | -36.3%#2 | 0.0%#1 |
| KPTI | $39M#4 | — | — | 0.3x#1 | 0.6%#4 | -156.5%#13 | -62.1%#2 | — | — | — | — | — |
| ELAB | $38M#5 | — | 2.3x#11 | 64.2x#10 | — | -24.0%#7 | -1304.4%#10 | -46.3%#5 | — | — | -99.7%#7 | — |
| CELU | $37M#6 | — | — | 1.4x#4 | -51.0%#7 | -58.4%#10 | -230.9%#6 | — | -398.1%#3 | — | — | — |
| CRVO | $37M#7 | 0.0x#1 | 1.6x#10 | 9.2x#9 | -58.9%#8 | -65.6%#11 | -706.2%#8 | -117.5%#10 | -5165.9%#5 | — | -70.1%#6 | — |
| LITS | $34M#9 | — | 0.6x#3 | — | -100.0%#10 | -189.7%#14 | — | -28.1%#4 | — | — | -62.4%#5 | — |
| FLNA | $33M#10 | — | 0.5x#1 | 0.8x#3 | 277.6%#2 | -273.7%#15 | -232.0%#7 | -133.5%#12 | — | — | — | — |
| RMTI | $32M#11 | 267.0x#5 | 0.9x#7 | 0.5x#2 | -31.8%#6 | -1007.1%#16 | -6.8%#1 | -15.1%#3 | -14.0%#2 | 4#3 | — | — |
| BRNS | $31M#12 | — | 0.5x#2 | — | -100.0%#10 | -8.8%#6 | — | -116.4%#9 | — | — | — | — |
| CPHI | $31M#13 | — | 0.9x#5 | 7.5x#8 | -8.5%#5 | 32.7%#4 | -78.2%#4 | -8.8%#1 | -7.7%#1 | 5#2 | — | — |
| KYNB | $31M#14 | 0.2x#2 | — | 4.8x#7 | -78.3%#9 | 485.6%#1 | -712.7%#9 | — | — | — | — | — |
| RNAZ | $31M#15 | — | — | — | — | -106.9%#12 | — | — | — | — | — | — |
| MIRA | $30M#16 | — | 3.7x#12 | — | — | -33.0%#8 | — | -127.9%#11 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice